Sign up to save your podcasts
Or
Share E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E48: ADACTA - Tocilizumab or Adalimumab in MTX Intolerant Patients with RA
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
View all episodes
By Michael Putman
4.9
111111 ratings
This week I revisit an old paper - the 2013 ADACTA trial that assessed tocilizumab and adalimumab for patients who cannot take or were intolerant of MTX.
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
315 Listeners
JAMA Clinical Reviews
498 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,331 Listeners
Core IM | Internal Medicine Podcast
1,107 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
197 Listeners
The Clinical Problem Solvers
517 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
350 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
70 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
174 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
19 Listeners